Healthcare Services

Biopharmaceutical CMO market trends shaping growth over the forecast period

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Biopharmaceutical CMO Market Over The 2026–2030 Period?

The biopharmaceutical CMO market has observed rapid expansion in recent years. Its valuation is anticipated to climb from $28.02 billion in 2025 to $32.03 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.3%. This historical growth can be linked to the escalating development of biologics pipelines, an increase in clinical trial activities, a heightened demand for adaptable manufacturing capacity, a rise in biosimilar approvals, and the presence of specialized biomanufacturing expertise.

The biopharmaceutical cmo market size is anticipated to experience swift expansion over the coming years. This market is projected to reach $54.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.2%. This growth during the forecast period is primarily driven by escalating investments in advanced biologics, a surging need for rapid scale-up manufacturing, the broadening of personalized therapies, increasing integration of continuous bioprocessing, and a greater emphasis on risk-sharing manufacturing models. Noteworthy trends for this period encompass the increased outsourcing of biologics manufacturing, a growing requirement for biosimilar production services, wider application of single-use bioprocessing systems, the expansion of cell and gene therapy manufacturing, and a heightened focus on comprehensive, end-to-end cmo capabilities.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

What Key Factors Are Affecting The Biopharmaceutical CMO Market Demand?

The expanding prevalence of chronic illnesses is anticipated to drive expansion within the biopharmaceutical CMO market in the future. These are enduring health conditions that remain throughout an individual’s life, frequently advancing gradually and necessitating continuous medical care. Biopharmaceutical CMOs are capable of improving efforts against chronic diseases by accelerating drug development, guaranteeing economical production, and upholding stringent quality benchmarks, consequently boosting the availability and economic viability of crucial medicines. For instance, in January 2024, the World Health Organization, an intergovernmental organization located in Switzerland, reported that the burden from noncommunicable diseases, primarily cardiovascular disease, cancer, chronic respiratory disease, and diabetes, continues to escalate. These diseases cause 41 million deaths annually, accounting for 74% of all deaths and the majority of premature mortality globally, with low- and middle-income countries bearing the greatest burden. Consequently, the growing prevalence of chronic diseases propels the biopharmaceutical CMOs market.

Which Segments Define The Biopharmaceutical CMO Market Segment Structure?

The biopharmaceutical cmo market covered in this report is segmented –

1) By Product: Biologics, Biosimilars

2) By Source: Mammalian, Non-Mammalian

3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging

Subsegments:

1) By Biologics: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell And Gene Therapies

2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Recombinant Proteins, Biosimilar Insulins, Biosimilar Growth Hormones

What Trends Are Influencing Changes In The Biopharmaceutical CMO Market?

Leading firms within the biopharmaceutical CMO market are increasingly engaging in strategic alliances to create novel biopharmaceutical products. Such collaborations aid biopharmaceutical CMO organizations by merging assets and specialized knowledge, boosting research and development capacities, broadening market presence, and hastening product launch, which ultimately fosters innovation and expansion in the biopharmaceutical CMO sector. An example of this is the partnership formed in May 2024 between BioConnection, a contract manufacturing company situated in the Netherlands, and AGC Biologics, a contract development and manufacturing company from the US. Through this alliance, their objective is to provide an integrated and efficient solution for biopharmaceutical development and manufacturing, thereby quickening schedules and streamlining procedures for those developing drugs.

Who Are The Established Players Within The Biopharmaceutical CMO Market?

Major companies operating in the biopharmaceutical cmo market are Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, Evonik Industries AG

Get The Full Biopharmaceutical CMO Market Report:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

Where Is The Biopharmaceutical CMO Market Most Concentrated Geographically?

North America was the largest region in the biopharmaceutical CMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biopharmaceutical CMO Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

Browse Through More Reports Similar to the Global Biopharmaceutical CMO Market 2026, By The Business Research Company

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Medical Biomimetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-biomimetics-global-market-report

Biosimilar Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795